Compressible liquid retention potential (ѱ-value) is defined as the maximum weight of liquid that can be retained per unit weight of the powder material in order to produce an acceptably compressible liquid or powder admixture. 7 The excipient ratio (R) or the carrier: coating material ratio is represented as follows: Where Ψ and ѱ are the Ψ-numbers of the carrier and coating material respectively. Therefore, the optimum liquid load factor (L 0 ) required to obtain acceptably flowing and compressible liquisolid systems is equal to either ϕ L f or ѱ L f , whichever represents the lower value.
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Classification of liquisolid systems
Based on the type of liquid medication contained therein, liquisolid systems may be classified into three sub-groups.
1) Powdered drug solutions 2) Powdered drug suspensions 3) Powdered liquid drugs
Powdered drug solutions and suspensions may be produced from the conversion of drug solutions or drug suspensions into liquisolid systems and powdered liquid drugs are produced from the formulation of liquid drugs into liquisolid systems.
Simultaneously, based on the formulation technique used, liquisolid systems may be classified into two categories namely,
1) Liquisolid compacts 2) Liquisolid microsystems
The term "liquisolid compacts" refers to immediate or sustained release tablets or capsules prepared and combined with the inclusion of appropriate adjuvants required for tabletting or encapsulation, such as lubricants, and for rapid or sustained release action, such as disintegrants or binders.
The term "liquisolid Microsystems" refers to capsules prepared by combining the drug with carrier and coating materials with inclusion of an additive e.g., PVP in the liquid medication wherein the resulting unit size may be as much as five times that of liquisolid compacts. 5 Main components of liquisolid technique are represented in table no 1. 2) Determination of angle of slide: To determine angle of slide required amount of carrier is weighed and placed at one end of a metal plate with a polished surface. The end is gradually raised till the plate becomes angular to the horizontal at which powder is about to slide. This angle is known as angle of slide. It was used as a measure of the flow properties of powders. Angle of 33° is regarded as optimum. 
3) Determination of flowable liquid retention potential:
The flowable liquid-retention potential (Φ value) of a powder material describes its ability to retain a specific amount of liquid while maintaining good flow properties. The Φ value is defined as the maximum weight of liquid, (W liquid ) that can be retained per unit weight of the sorbent (W solid ), yielding a mixture with acceptable flowability, W liquid /W Solid As the flowable liquid-retention potential of the carrier material is approached, the liquid is held entirely in the interior of the particles. This maintains the surface of carrier material relatively dry, thus yielding powders with acceptable flow properties. When the Φ value is exceeded, the interior of particles become saturated, resulting in the formation of a liquid layer on the available surface of carrier particles. The liquid load factor that ensures acceptable flowability (L f ), and can be measured by:
4) Liquisolid compressibility test: It was developed to
determine Ψ values and involves steps such as preparing carrier coating material admixture systems, preparing several uniform liquid/powder admixtures to tablets, determining average hardness, measuring of average liquid content of crushed tablets, as well as determining plasticity, sponge index and Ψ value and L f .
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Preparation of Liquisolid Tablets
A calculated quantity of drug should be dispersed in the non volatile solvent system (Polysorbate 80, Poly Ethylene Glycol-200) termed as liquid vehicle with different drug: vehicle ratio. Then resulting hot medication should be incorporated into carrier and coating material under continuous mixing in a mortar. Mixing process is to be carried out in three steps which is shown in fig. no. 1.
Step1. System is blended at an appropriate mixing rate of one rotation per second for approximately one minute in order to evenly distribute liquid medication in the powder.
Step 2: The liquid / powder admixture is evenly spread as a uniform layer on the surface of a mortar and left standing for approximately 5 minute to allow dug solution to be absorbed in the interior of powder particle.
Step 3: Powder is scraped off the motor surface by mean of aluminium spatula and then blended with disintegrant like Sodium Starch Glycolate and other remaining additives are added according to their application and mixed for a period of 10 to 20 minute in a mortar.
The final mixture should be compressed using the manual tabletting machine to achieve tablet hardness. It is used to know the possible interactions between drug and excipients used in the formulation. If the characteristic peak for the drug is absent in the DSC thermogram, there is an indication that the drug is in the form of solution in liquisolid formulation and hence it is molecularly dispersed within the system. Thermal properties of the untreated drug and prepared samples are analyzed by DSC. About 5 mg of sample is heated in a hermetically sealed aluminium pans. Heat runs for each sample were set from 30°C to 350°C at a heating rate of 10°C/ min, using nitrogen atmosphere of flow rate 100ml/ minute. 16 
2) Fourier transform infra-red spectroscopy (FTIR):
It is a technique which is used to obtain an infrared spectrum of absorption, emission and Raman scattering of a solid, liquid or gas. FTIR spectrometer simultaneously collects spectral data in a wide spectral range. FTIR spectrum of the drug and the prepared samples were subjected to IR spectrophotometer under identical conditions by Potassium Bromide pellet technique. Spectrum is collected over a region of 4000-400 cm -1 .
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3) X ray diffraction (XRD): A primary use of the technique is the identification and characterization of compounds based on their diffraction pattern. For the characterization of crystalline state, (XRD) patterns are determined for physical mixture of drug and excipients used in formulation and for the prepared liquisolid compacts. Absence of constructive specific peaks of the drug in the liquisolid compacts in X-ray diffractogram specify that drug has almost entirely converted from crystalline to amorphous or solubilised form. Such lack of crystallinity in the liquisolid system was understood to be as a result of drug solubilization in the liquid vehicle i.e., the drug has formed a solid solution within the carrier matrix. This solubilization of drug in the liquisolid compacts it may contribute to the consequent improvement in the apparent solubility and enhancement of dissolution rate of the drug.
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Precompression Studies of Liquisolid Preparation
1) Angle of repose:
Angle of repose can be measured by fixed funnel method. The frictional forces in loose powder or granules can be measurement by the angle of repose. This is the maximum angle possible between the surface of a pile of powder or granules and the horizontal plane. Thus, r being the radius of the base of the conical pile. 17 This is shown in table no 3.
Tan θ = h/r Mixing process is carried out in three steps
Step 1: Mixture is rotated for 1 rotation per second for one minute for complete mixing of liquid medication in powder
Step 2: This mixture is spread over the motar for 5 minute so that drug get absorbe in the intrior of powder
Step Post Compression Evaluations 1) Hardness: Monsanto hardness tester can be used for the determination of the hardness. The tablet to be tested was held between a fixed and moving jaw and reading of the indicator adjusted to zero. The force applied to the edge of the tablet is gradually increased by moving the screw knob forward until the tablet breaks. Reading is noted down and is expressed in kg/cm. 19 2) Thickness: The crown to crown thickness of tablets is measured by Vernier Caliper. It is expressed in mm. the thickness variation allowed are ± 5% of the size of the tablet.
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3) Weight variation: 20 tablets are selected randomly from the lot and weighed individually to check for weight variation. 19 Pharmacopoeial limits are shown in table no 6. 
4) Uniformity of Drug content:
5) The drug content can be determined by triturating sufficient amount of tablets and powder equivalent to average weight was added in 100 ml of suitable buffer solution. Followed by stirring for 30 min. Dilute suitably and the absorbance of resultant solution was measured spectrophotometrically. 
6) In-vitro drug release studies:
The release rate of drug from tablets can be determined using USP dissolution testing apparatus 2 (paddle method). The dissolution test performed using 900 ml of suitable buffer solution at 37±0.5ºC. in to the system. 6) Production cost is low compared to that of preparation of soft gelatin capsules. 
Flow property C.I (%)
Liquisolid Technique in the Formulation of Sustained Release Tablets
Development of sustained release oral dosage form is beneficial for optimal therapy in terms of efficacy, safety and patient compliance. Several methods have been developed to this end or to achieve this aim. It is suggested that liquisolid technique has the potential to be optimised for the reduction of drug dissolution rate and there by production of sustained release system. 21 Sustained release dosage forms are designed to release the drug at a predetermined rate by maintaining a constant drug release for specific period of time with minimum side effects in terms of efficacy, safety and patient compliance. Ideally, controlled release formulations will provide therapeutic concentration of the drug in the blood which is maintained throughout the dosing interval. Liquisolid technique is a new approach to alter the dissolution properties of the drug by using hydrophobic carriers instead of hydrophilic carriers. 3 The presence of non-volatile solvent reduces the glass transition temperature (Tg) of polymer and imparts flexibility. Therefore, reduction of Tg of the polymer might be the reason for the release prolongation of liquisolid tablets. In the temperature above the Tg, a better coalescence of the polymer particle occurs that form a fine network and a matrix with lower porosity an higher tortusity. In this way, the drug is surrounded by the polymer network, resulting in the restricted leaching of the drug thus sustained the release of drug from the liquisolid matrix. 21 Review of the drug molecules with sustained release liquisolid compact is shown in table no 7. 
